FDA Inspection
I 3 PHARMACEUTICALS, LLCI 3 PHARMACEUTICALS, LLC – FDA Inspection, May 22, 2026
Record Details
This FDA Inspection record concerns I 3 PHARMACEUTICALS, LLC, with an inspection on May 22, 2026, issued by the Philadelphia District Office, covering human drugs.
View Company Profile
ID · e8197bab-6839-40f8-a925-d65007aa8156
Inspection Facts
- Inspection number
- 1320356
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of I 3 PHARMACEUTICALS, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 22, 2024 | Not classified | Philadelphia District Office | |
| March 3, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 21, 2018 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
Other documents for I 3 PHARMACEUTICALS, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.